- Home
- HIFS vs KALV Comparison
HIFS vs KALV Comparison
Compare HIFS & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIFS
- KALV
- Stock Information
- Founded
- HIFS 1834
- KALV N/A
- Country
- HIFS United States
- KALV United States
- Employees
- HIFS N/A
- KALV N/A
- Industry
- HIFS Major Banks
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- HIFS Finance
- KALV Health Care
- Exchange
- HIFS Nasdaq
- KALV Nasdaq
- Market Cap
- HIFS 603.3M
- KALV 482.8M
- IPO Year
- HIFS N/A
- KALV N/A
- Fundamental
- Price
- HIFS $270.14
- KALV $8.69
- Analyst Decision
- HIFS
- KALV Strong Buy
- Analyst Count
- HIFS 0
- KALV 5
- Target Price
- HIFS N/A
- KALV $27.67
- AVG Volume (30 Days)
- HIFS 10.5K
- KALV 372.0K
- Earning Date
- HIFS 01-17-2025
- KALV 12-24-2024
- Dividend Yield
- HIFS 0.92%
- KALV N/A
- EPS Growth
- HIFS N/A
- KALV N/A
- EPS
- HIFS 10.55
- KALV N/A
- Revenue
- HIFS $58,408,000.00
- KALV N/A
- Revenue This Year
- HIFS N/A
- KALV N/A
- Revenue Next Year
- HIFS N/A
- KALV N/A
- P/E Ratio
- HIFS $25.93
- KALV N/A
- Revenue Growth
- HIFS N/A
- KALV N/A
- 52 Week Low
- HIFS $150.11
- KALV $8.48
- 52 Week High
- HIFS $300.00
- KALV $16.88
- Technical
- Relative Strength Index (RSI)
- HIFS 44.87
- KALV 37.81
- Support Level
- HIFS $273.30
- KALV $8.52
- Resistance Level
- HIFS $286.00
- KALV $9.22
- Average True Range (ATR)
- HIFS 6.31
- KALV 0.60
- MACD
- HIFS -1.91
- KALV -0.04
- Stochastic Oscillator
- HIFS 0.00
- KALV 10.50
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.